Who Owns IGC?

IGC Pharma, Inc. — Institutional Ownership & 13F Holdings

$0.31

-0.01 (-2.09%)

Market Cap

$27.5M

Shares Outstanding

98,796,089

Institutional Holders

25

Total Inst. Value

$813K

% of Float Held

QoQ Holder Change

+1

Institutional data as of Q1 2025

New Positions

2

Closed Positions

6

Increased

6

Decreased

5

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BlackRock, Inc.$201K703,798
2GEODE CAPITAL MANAGEMENT, LLC$198K700,014
3VANGUARD GROUP INC$183K645,166
4STATE STREET CORP$47K165,307
5Squarepoint Ops LLC$40K140,510
6NORTHERN TRUST CORP$32K113,407
7CITADEL ADVISORS LLC$27K94,471
8DEARBORN PARTNERS LLC$24K84,401
9GOLDMAN SACHS GROUP INC$19K65,541
10TRUIST FINANCIAL CORP$10K36,667

Biggest Buyers & Sellers This Quarter

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold IGC?

As of Q1 2025, 25 institutional investors report holding IGC (IGC Pharma, Inc.) in their 13F filings.

Which hedge fund owns the most IGC?

The largest institutional holder of IGC is BlackRock, Inc. with $201K in shares.

Are institutions buying or selling IGC?

This quarter, 2 institutions opened new positions in IGC and 6 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.